Medicare Part D 2011 Data Spotlight: The Coverage Gap September 7, 2011 Report This data spotlight examines the availability of gap coverage in the private Medicare Part D drug plans offered to beneficiaries in 2011, the first year of the phase-out of the gap, as required under the 2010 health reform law. The changes for 2011 include a 50 percent discount on brand-name…
Understanding The Effects of The Medicare Part D Coverage Gap in 2008 and 2009 August 30, 2011 Report This Kaiser Family Foundation study examines how the coverage gap in Medicare’s drug benefit known as the “doughnut hole” affects Medicare beneficiaries and their prescribing patterns. Based on actual claims data from 2008 and 2009, before the 2010 health reform law began to close the gap, the study finds that…
Making Ends Meet: The Medicare Generation June 1, 2011 Video This short Kaiser Family Foundation documentary profiles the experiences of three Medicare families trying to pay for their health care costs with other household spending. The families are among 16 featured in a companion report examining the role Medicare now plays in the lives of beneficiaries and the challenges many…
A Primer on Medicare Financing January 31, 2011 Issue Brief As Congress and the Administration increasingly focus on the nation’s budget deficit, many policy experts and several bipartisan deficit reduction panels have proposed significant changes to Medicare to reduce federal spending and address rising health care costs. This primer provides an overview of Medicare spending trends, how the program is…
Reaching for the Stars: Quality Ratings of Medicare Advantage Plans, 2011 January 31, 2011 Issue Brief New: Medicare Advantage Plan Star Ratings and Bonus Payments in 2012 In 2012, Medicare Advantage plans will be awarded additional payments based on their quality ratings as a result of the 2010 health reform law. The Centers for Medicare and Medicaid Services has proposed a demonstration that would modify the…
Medicare Chartbook, 2010 October 30, 2010 Report This chartbook provides the most recent and reliable data available about the Medicare program and the 47 million seniors and younger people with disabilities who get health insurance coverage through the program. Topics covered include: Medicare beneficiaries; the program’s benefits, utilization, and access to care; prescription drugs; the Medicare Advantage…
Medicare Advantage 2011 Data Spotlight: Plan Availability and Premiums September 30, 2010 Report This Medicare Advantage Data Spotlight provides an overview of recent changes made to the Medicare Advantage program and examines trends in plan participation, premiums and certain benefits. About 12 million people, or nearly a quarter of the Medicare population, are enrolled in Medicare Advantage, the privately administered plans that…
Medicare Part D Spotlight: Part D Plan Availability in 2011 and Key Changes Since 2006 September 29, 2010 Report This initial analysis examines the private stand-alone Part D drug plans will be available to Medicare beneficiaries in 2011 and provides an early look at key trends in the options, premiums, and other plan characteristics. It finds that the average Medicare beneficiary will have a choice of 33 Part D…
The Medicare Part D Low-Income Subsidy Program: Experience to Date and Policy Issues for Consideration September 1, 2010 Issue Brief This policy brief examines the low-income subsidy program that provides premiums and cost-sharing assistance under Part D plans, documenting trends in both beneficiary and plan participation over time. With fewer plans available to low-income enrollees without having to pay a premium, and annual changes in those plans, the brief discusses…
Medicare Part D 2010 Data Spotlight: Coverage of Top Brand-Name and Specialty Drugs August 31, 2010 Issue Brief This Part D Data Spotlight documents the wide variations across the private stand-alone drug plans with respect to coverage of drugs, what enrollees pay for those drugs, and restrictions and limitations placed on their use. These variations have potentially significant implications for beneficiaries’ access to medications and out-of-pocket costs. The…